BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Bot Chart, page-33

  1. 691 Posts.
    lightbulb Created with Sketch. 142
    Looking at the team, it appears this could go one of two ways, either an early TO, or move into Operations & Manufacturing.

    what is required?

    A few things:

    1. Positive results.
    2. License deals for the P tech
    3. Partnership deals (if BOT decides against a TO)

    Evidence for the canna is overwhelmingly positive. As I have said previously, P tech is the key.

    if it all comes together, this should be worth closer to $2-3b.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.